U.S. Consumer Finance Stock News

DoubleVerify Holdings (DV) has seen its stock performance struggle lately, with shares drifting lower over the past month as well as the past 3 months. Investors might be weighing the company’s recent results alongside ongoing market challenges. See our latest analysis for DoubleVerify Holdings. DoubleVerify’s momentum has clearly faded, with its share price down sharply so far this year and the one-year total shareholder return reflecting a similar drop. This retreat has some investors...

AbbVie (ABBV) is making headlines after posting strong third quarter earnings, raising its 2025 guidance, and securing additional years of patent protection through a fresh legal settlement with generic rivals. See our latest analysis for AbbVie. Momentum is clearly building around AbbVie as bullish news and confident earnings have fueled a 12.5% gain in its share price over the past 90 days, with the stock up an impressive 29.5% year-to-date. When you factor in reinvested dividends, the...

TechnipFMC (FTI) shares have moved up around 1% over the past day, continuing a steady upward trend this month. Investors are taking note of its solid year-to-date return as well as its overall multi-year performance. See our latest analysis for TechnipFMC. That upward momentum is hard to ignore, especially with TechnipFMC posting a 1.23% one-day share price gain and an impressive 47.75% share price return so far this year. The company’s one-year total shareholder return of 56% and an even...

Cabot (CBT) recently announced its fourth quarter and full year financial results, with both sales and net income coming in lower than the previous year. This drop in performance has naturally caught the attention of investors. See our latest analysis for Cabot. Cabot's recent earnings miss and the accompanying leadership shift appear to have intensified selling pressure. The stock posted a 30.7% share price decline year-to-date and a total shareholder return of -42.2% over the past year...

Array Technologies, Inc. has reported third quarter 2025 earnings, achieving sales of US$393.49 million and net income of US$33.5 million, reversing last year’s net loss and providing updated annual revenue guidance in the range of US$1.25 billion to US$1.28 billion. The company’s return to profitability, significantly higher sales, and fresh full-year outlook offer investors enhanced clarity into operational momentum and future expectations. We'll examine how this turnaround in quarterly...

Victory Capital Holdings (VCTR) has revealed steady growth in assets under management as of October 2025, with gains in both global and U.S. large-cap equities. This, combined with recent earnings momentum and share repurchases, draws renewed investor attention. See our latest analysis for Victory Capital Holdings. Recent months have seen Victory Capital Holdings complete a significant share buyback program and deliver third-quarter results featuring stronger revenue and net income...

Interface (TILE) shares have caught attention following a recent event, prompting investors to consider how it might shape the company’s outlook. Many are now examining Interface’s valuation and underlying business fundamentals. See our latest analysis for Interface. Interface’s share price has gained 8.3% so far this year, with solid three- and five-year total shareholder returns of 142% and 203% respectively. This suggests that long-term momentum is very much alive, even after a few recent...

Over the past quarter, Progressive completed its planned share repurchase program, buying back 193,948 shares for a total of US$49.13 million and reporting revenues that rose 14.2% year on year, though it fell short of analyst estimates for earnings per share and book value per share. Several major analysts recently downgraded Progressive, citing concerns about moderating investment income as interest rates decline and margin pressure from targeted rate reductions, despite solid...

AGNC Investment (AGNC) has caught investors' attention lately, as its share price remains stable after recent market activity. Investors are curious about what might be driving the stock’s modest momentum and how it fits into longer-term performance. See our latest analysis for AGNC Investment. AGNC Investment’s share price has edged up 1.6% over the past month and delivered a notable 9.4% return year-to-date. The bigger story is its 23.2% total shareholder return over the last year, which...

News (NWSA) shares have seen some movement lately, catching the attention of investors who are curious about what might be driving the stock’s recent changes. In the past month, the stock has edged up just under 1%. See our latest analysis for News. After a long stretch of sideways trading, News shares have lost some momentum in recent months, with a 1-year total shareholder return of -7.98% and a 90-day share price return of -11.45%. Even with a healthy run over the last five years, recent...

Fortive (FTV) shares have rebounded about 6% over the past month, even as the stock remains down year to date. Investors are watching closely as recent performance hints at shifting momentum following a stretch of slower growth. See our latest analysis for Fortive. Fortive’s recent recovery has started to catch investors’ attention, with its 6% one-month share price return providing a welcomed shift after a tough stretch. Although the stock is still down significantly year to date, the steady...

Bausch Health Companies (NYSE:BHC) has announced the commercial expansion of its OraPharma business into Canada and Puerto Rico. By entering these markets, the company aims to broaden access to periodontal disease treatments and foster new partnerships. See our latest analysis for Bausch Health Companies. Despite Bausch Health Companies’ big move to expand its OraPharma dental products into Canada and Puerto Rico, investors have seen mixed signals. The stock has posted a 3.8% one-month share...

Nektar Therapeutics (NKTR) announced a $110 million follow-on equity offering, along with new shelf registrations for multiple securities. Moves like this can reshape the company's capital position and influence how investors gauge its future outlook. See our latest analysis for Nektar Therapeutics. This fresh fundraising push comes shortly after Nektar Therapeutics’ recent FDA fast track designations, new product data, and a third-quarter earnings report showing narrower year-over-year...

Earlier this month, Booking Holdings Inc. completed a €750 million fixed-rate senior unsecured note offering, introducing 3% callable Eurobonds due in November 2030 as part of its capital-raising efforts. The announcement comes alongside positive quarterly results and increased annual savings forecasts, highlighting management’s confidence in both operational momentum and cost transformation initiatives. To better understand what these events signal, we'll explore how improved savings...

PureCycle Technologies, Inc. recently grabbed headlines after winning the 2025 U.S. Plastics Pact Sustainable Packaging Innovation Award. The company also posted quarterly results that showed narrower losses and announced new regulatory milestones in Europe. See our latest analysis for PureCycle Technologies. After a surge of attention from its sustainability award win and the appointment of a new director, PureCycle’s 1-day share price return of 3.49% hints at rising optimism. However, with...

Insulet (PODD) is catching attention after releasing its third quarter results, showing clear jumps in sales and net income from last year. The company also boosted its revenue outlook for its Omnipod line, which signals confidence in future growth. See our latest analysis for Insulet. Momentum has been building for Insulet this year, with its upbeat earnings and a boost in revenue guidance helping to drive investor optimism. The share price is up 29.5% year-to-date, and the company’s...

Earlier this month, Centene Corporation announced expanded Ambetter health insurance plan offerings for 2026 in Arizona, Mississippi, and Georgia, emphasizing affordable plans, customizable coverage, and enhanced member benefits such as Ambetter Perks, My Health Pays rewards, and 24/7 telehealth services. This expansion highlights Centene's ongoing focus on consumer-friendly digital enrollment, value-added programs, and tailored employer solutions, which may play a role in membership growth...

Aptiv (APTV) delivered strong third-quarter earnings that surpassed expectations, sparking investor interest ahead of its upcoming analyst day. The company is also set to discuss a possible spin-off of its software division, which hints at a new strategic focus. See our latest analysis for Aptiv. Aptiv’s upbeat earnings and its fresh robotics partnership with Robust.AI have put the spotlight back on the company’s transformation story, helping spark considerable momentum in the stock. While...

Clarivate recently reported its fiscal Q3 2025 results, showing a modest revenue increase driven by higher transactional sales in the government and academic sectors, and raised its full-year revenue outlook amid favorable currency effects. An interesting insight is that while transactional book sales and currency movements provided a boost, recurring subscription revenue growth came in below expectations, signaling ongoing challenges to sustainable long-term growth. We'll explore how...

ManpowerGroup (MAN) shares have continued their steady slide in recent weeks, with the stock down 15% over the past month. Investors are watching for signs of recovery as the staffing leader faces ongoing challenges. See our latest analysis for ManpowerGroup. ManpowerGroup's challenges have only accelerated this year, with the stock’s 30-day share price return at -15% and its year-to-date decline nearing 50%. A one-year total shareholder return of -52% highlights how far sentiment and...

Crinetics Pharmaceuticals (CRNX) just released its third quarter financials, showing a wider net loss compared to last year. This update is important for investors keeping an eye on the company’s trajectory. See our latest analysis for Crinetics Pharmaceuticals. Despite the steeper losses just reported, Crinetics Pharmaceuticals has climbed sharply in recent months, with a 43% share price return over the last quarter. However, momentum has yet to fully recover from longer-term declines...

Tetra Tech reported record financial results for the fourth quarter and fiscal year 2025, including record net revenue, operating income, and earnings per share, alongside a 12% year-on-year increase in its quarterly dividend payable on December 12, 2025. The company highlighted strong growth in high-end water infrastructure and digital automation services, while also announcing major contract wins with U.S. defense agencies and international clients, contributing to an expanding project...

Nelnet recently reported third-quarter and nine-month earnings, with net income reaching US$106.68 million for the quarter and US$370.7 million year-to-date, and also declared a US$0.33 per share dividend to be paid in December 2025. The company’s results reflect a dramatic rise in profitability compared to the previous year, driven by substantial gains in both quarterly and year-to-date earnings per share. We'll examine how Nelnet's significant earnings jump and shareholder dividend...

In recent announcements, MarketAxess Holdings reported third quarter and nine-month financial results, affirmed its quarterly dividend of US$0.76 per share, completed a US$95.33 million share buyback, and revealed the imminent launch of standardized Opening and Closing Auctions for U.S. credit trading on its platform. Consulting with major institutional participants to develop its new auction protocol highlights MarketAxess’s ongoing focus on enhancing liquidity and price discovery in the...